Terns Pharmaceuticals, Inc.
TERN
DELAYED 1 MONTH

9 insider filings · Latest: May 5, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 5, 2026May 5 9:08 PMRobert AzelbyDirector
Disposition
91,697$34.600(D)

View →

May 5, 2026May 5 9:07 PMHeather D TurnerDirector
Disposition
110,697$34.600(D)

View →

May 5, 2026May 5 9:06 PMRadhika TripuraneniDirector
Disposition
190,030$34.600(D)

View →

May 5, 2026May 5 9:05 PMJill M. QuigleyDirector
Disposition
147,309$34.600(D)

View →

May 5, 2026May 5 9:04 PMJeffrey B KindlerDirector
Disposition
208,505$34.600(D)

View →

May 5, 2026May 5 9:03 PMDavid A FellowsDirector
Disposition
221,136$34.600(D)

View →

May 5, 2026May 5 9:02 PMEmil KuriakoseChief Medical Officer
Disposition
1,115,000$37.180(D)

View →

May 5, 2026May 5 9:01 PMAndrew GengosChief Financial Officer
Disposition
887,500$37.180(D)

View →

May 5, 2026May 5 9:00 PMAmy L. BurroughsDirector, Chief Executive Officer
Disposition
2,505,534$37.180(D)

View →